Eris Lifesciences Balans Gezondheid
Financiële gezondheid criteriumcontroles 3/6
Eris Lifesciences heeft een totaal eigen vermogen van ₹31.8B en een totale schuld van ₹27.0B, wat de schuld-eigenvermogensverhouding op 84.8% brengt. De totale activa en totale passiva bedragen respectievelijk ₹70.2B en ₹38.4B. De EBIT Eris Lifesciences is ₹5.8B waardoor de rentedekking 3.6 is. Het heeft contanten en kortetermijnbeleggingen van ₹2.4B.
Belangrijke informatie
84.8%
Verhouding schuld/eigen vermogen
₹26.95b
Schuld
| Rente dekkingsratio | 3.6x |
| Contant | ₹2.43b |
| Aandelen | ₹31.77b |
| Totaal verplichtingen | ₹38.45b |
| Totaal activa | ₹70.22b |
Recente financiële gezondheidsupdates
Here's Why Eris Lifesciences (NSE:ERIS) Can Manage Its Debt Responsibly
Nov 21
Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly
Aug 04Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly
Dec 07Does Eris Lifesciences (NSE:ERIS) Have A Healthy Balance Sheet?
Nov 20These 4 Measures Indicate That Eris Lifesciences (NSE:ERIS) Is Using Debt Safely
Jun 20Recent updates
Here's Why Eris Lifesciences (NSE:ERIS) Can Manage Its Debt Responsibly
Nov 21Eris Lifesciences Limited Just Missed EPS By 8.6%: Here's What Analysts Think Will Happen Next
Oct 30A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)
Oct 15Eris Lifesciences Limited's (NSE:ERIS) CEO Compensation Looks Acceptable To Us And Here's Why
Sep 19Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS) As Its Stock Soars 27%
Sep 03Earnings Update: Eris Lifesciences Limited (NSE:ERIS) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts
Aug 05Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly
Aug 04Estimating The Intrinsic Value Of Eris Lifesciences Limited (NSE:ERIS)
Jul 13Eris Lifesciences Limited (NSE:ERIS) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
May 24Why We're Not Concerned About Eris Lifesciences Limited's (NSE:ERIS) Share Price
May 10An Intrinsic Calculation For Eris Lifesciences Limited (NSE:ERIS) Suggests It's 25% Undervalued
Mar 14Analyst Estimates: Here's What Brokers Think Of Eris Lifesciences Limited (NSE:ERIS) After Its Third-Quarter Report
Feb 15Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS)
Dec 28Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly
Dec 07Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?
Nov 11Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?
Jul 20Does Eris Lifesciences (NSE:ERIS) Have A Healthy Balance Sheet?
Nov 20These 4 Measures Indicate That Eris Lifesciences (NSE:ERIS) Is Using Debt Safely
Jun 20A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)
Feb 24Is Now The Time To Put Eris Lifesciences (NSE:ERIS) On Your Watchlist?
Dec 28Here's Why I Think Eris Lifesciences (NSE:ERIS) Might Deserve Your Attention Today
Sep 23If You Like EPS Growth Then Check Out Eris Lifesciences (NSE:ERIS) Before It's Too Late
May 26Eris Lifesciences Limited (NSE:ERIS) Shares Could Be 34% Above Their Intrinsic Value Estimate
Apr 17Eris Lifesciences Limited's (NSE:ERIS) Stock Has Fared Decently: Is the Market Following Strong Financials?
Mar 12Does Eris Lifesciences (NSE:ERIS) Deserve A Spot On Your Watchlist?
Feb 25Why Eris Lifesciences Limited (NSE:ERIS) Is A Dividend Rockstar
Feb 12Eris Lifesciences Limited (NSE:ERIS) Analysts Are Pretty Bullish On The Stock After Recent Results
Jan 30
Read This Before Buying Eris Lifesciences Limited (NSE:ERIS) Shares
Jan 17Our View On Eris Lifesciences' (NSE:ERIS) CEO Pay
Dec 30Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( ₹13.2B ) ERIS } overtreffen de korte termijn passiva ( ₹12.3B ).
Langlopende schulden: De kortetermijnactiva van ERIS ( ₹13.2B ) dekken de langetermijnschulden ( ₹26.1B ) niet.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 77.2% ) ERIS wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van ERIS is de afgelopen 5 jaar gestegen van 1% naar 84.8%.
Schuldendekking: De schuld van ERIS wordt goed gedekt door de operationele kasstroom ( 26.2% ).
Rentedekking: De rentebetalingen op de schuld van ERIS worden goed gedekt door EBIT ( 3.6 x dekking).